Massachusetts state leaders confirmed this week that local funds will step in to cover gender-affirming medical treatments for low-income trans youth following a new policy shift from the federal government.
A finalized rule from the federal Centers for Medicare & Medicaid Services cuts off federal dollars for trans care provided to minors under public insurance programs. Set to take effect Oct. 13, the policy blocks Medicaid and Children’s Health Insurance Program funding for patients younger than 18 and 19, respectively.
The Healey-Driscoll administration plans to plug that gap using the state’s $8.5 million Affirming Health Care Trust Fund.
State Response To Federal Action
The policy change, announced by CMS Administrator Dr. Mehmet Oz, targets public health programs that low-income and disabled families depend on. Oz argued the rule changes align with the administration’s focus on limiting access for minors.
“Children deserve our protection, not experimental interventions that pose serious risks and convey no proven benefits,” Oz said in a statement. “By cutting off federal funds for these sex-rejecting procedures, we’re following the science, saving taxpayer dollars, and, most importantly, protecting children from potentially irreversible harm so they can truly flourish.”
The federal government generally covers 50% of standard Medicaid costs in Massachusetts and 65% of CHIP costs. Removing these matching funds leaves state officials scrambling to calculate exact costs, though state records show MassHealth spent $3.6 million on youth transition care in 2024. The majority of that total, $2.6 million, paid for hormone replacement therapies.
Gov. Maura Healey pushed back directly against the white house directive.
“President Trump continues to attack the health and wellbeing of all people,” Healey said. “Here in Massachusetts, we are going to keep working with providers to make sure that everyone, including LGBTQ residents, can get the essential health care they need.”
Local Impact And Legal Challenges
Data from medical billing records reveals that roughly 550 MassHealth recipients under 19 received hormone replacement therapy or puberty blockers in 2024. Surgical interventions remain rare; zero bottom surgeries were billed through MassHealth for minors that same year.
Despite the small number of patients directly utilizing the insurance benefits, federal pressure has already changed the local landscape. Clinical sites like Baystate Health, Fenway Health, and Outer Cape Health Services halted hormone therapy and puberty blocker access for youth following months of federal investigations and regulatory declarations.
LGBTQ+ advocacy groups and state legal representatives are preparing for a protracted fight. Tanya Neslusan, executive director of MassEquality, called out the policy’s real motivations.
“This is bigotry masquerading as healthcare policy,” Neslusan said. “This is not about protecting children. It is about targeting transgender people and putting politicians between patients, parents, and their doctors.”
Massachusetts Attorney General Andrea Joy Campbell announced her office will sue to halt the directive before October, arguing that federal agencies are overstepping their legal bounds.
“Transgender young people deserve to live with dignity, respect, and the freedom to access lifesaving healthcare that supports their emotional and physical wellbeing,” Campbell said. “The fact remains that federal law does not prohibit gender-affirming care for minors, and Massachusetts law continues to protect this care.”
The federal rule includes a six-month transition period starting in October for patients currently prescribed hormone therapies. Coverage for mental health counseling under MassHealth and CHIP remains untouched by the new regulation.
